newsfilter
← Latest News
PR Newswire·

TC BioPharm Announces Key Additions to Scientific Advisory Board, Expanding Cell Therapy Expertise

SAB selected to advance new therapeutic trials and strategic partnerships EDINBURGH, Scotland, Oct. 26, 2022 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ:TCBP)